Skip to main content
Search

The multidimensional landscape of pharmacovigilance: introduction and history

Part 1 of 2
Published on June 29, 2023   33 min

A selection of talks on Pharmaceutical Sciences

Please wait while the transcript is being prepared...
0:00
Ladies and gentlemen, my name is Ulrich Hagemann. Welcome to this talk about the multidimensional landscape of pharmacovigilance.
0:13
I got my university education in Pharmacy and Biochemistry at the Free University of Berlin. Thereafter I started to work for the German medicines National Drug Agency, the Federal Institute of drugs and medical devices, first in Berlin and later in Bonn. Since 1996, I was leading the pharmacovigilance department at this institute until my retirement in 2011. Currently, I'm retired and a member of the Editorial Board, of the International Journal of Risk and Safety in Medicine.
0:55
These are my conflicts of interests. I have no conflicts of interests to be declared. The views expressed in this presentation reflect my personal views of the issue.
1:09
I have decided to divide my talk into two parts because there are different issues which relate to pharmacovigilance, but which are not really straightforward connected. In this first part, I would like to talk about the history and disasters in pharmacovigilance, I would like to address the science and knowledge which are needed in pharmacovigilance and the areas of research. I would like to outline what is the link between pharmacovigilance and public health and what is the needed clinical medicine expertise in pharmacovigilance.

Quiz available with full talk access. Request Free Trial or Login.

Show
Hide

The multidimensional landscape of pharmacovigilance: introduction and history

Embed in course/own notes